top of page

PBMs, Big Pharma face off in House hearing

Pharmacy benefit managers emerged as public enemy No. 1 in a congressional hearing Tuesday, underscoring growing bipartisan sympathy for advancing any of the many measures that target drug industry middlemen.

bottom of page